Treat-to-Target in Axial Spondyloarthritis: Are we there yet?

por Aouad, Krystel, El-Zorkany, Bassel
Publicado 2022

The treatment journey for patients with axial spondyloarthritis in North Africa and the Middle East: From diagnosis to management

por El Zorkany, Bassel, Ali, Yaser Mustafa, Namas, Rajaie, Bedaiwi, Mohamed, Husain, Waleed, Ahmed, Haytham Mohamed, Ziade Zoghbi, Nelly
Publicado 2020

Biosimilars in rheumatology: recommendations for regulation and use in Middle Eastern countries

por El Zorkany, Bassel, Al Ani, Nizar, Al Emadi, Samar, Al Saleh, Jamal, Uthman, Imad, El Dershaby, Yasser, Mounir, Mohamed, Al Moallim, Hani
Publicado 2018

Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and...

por Bird, Paul, Bensen, William, El-Zorkany, Bassel, Kaine, Jeffrey, Manapat-Reyes, Bernadette Heizel, Pascual-Ramos, Virginia, Witcombe, David, Soma, Koshika, Zhang, Richard, Thirunavukkarasu, Krishan
Publicado 2019

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

por Dougados, Maxime, Soubrier, Martin, Antunez, Anna, Balint, Peter, Balsa, Alejandro, Buch, Maya H, Casado, Gustavo, Detert, Jacqueline, El-zorkany, Bassel, Emery, Paul, Hajjaj-Hassouni, Najia, Harigai, Masayoshi, Luo, Shue-Fen, Kurucz, Reka, Maciel, Gabriel, Mola, Emilio Martin, Montecucco, Carlo Maurizio, McInnes, Iain, Radner, Helga, Smolen, Josef S, Song, Yeong-Wook, Vonkeman, Harald Erwin, Winthrop, Kevin, Kay, Jonathan
Publicado 2014